FWG Holdings’s Lexicon Pharmaceuticals LXRX Stock Holding History

FWG Holdings’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-11,350	Closed	-$18K	–	134
2026 Q1	$18K	Hold	11,350	–	–	0.01%	125
2025 Q4	$13.2K	Buy	+11,350	New	+$15.6K	0.01%	127

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FWG Holdings's LXRX Position: Q2 2026 in Review

FWG Holdings sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2026, closing a stake of 11,350 shares — an estimated $18K sold.

FWG Holdings first reported a position in LXRX in Q4 2025 and held it in 2 quarters. The position peaked at $18K in Q1 2026. 148 funds tracked by Wall St. Rank hold LXRX as of Q2 2026.

FWG Holdings reported no remaining Lexicon Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
FWG Holdings sold 11,350 Lexicon Pharmaceuticals shares in Q2 2026, an estimated $18K.
FWG Holdings first reported a position in Lexicon Pharmaceuticals in Q4 2025 and held it in 2 quarters.
FWG Holdings's Lexicon Pharmaceuticals position peaked at $18K in Q1 2026.
148 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2026.

Based on FWG Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.